Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 10 hours ago
Scribe notes down IPO ambition to fund lipid-lowering genetic meds through clinical trials
about 10 hours ago
Scribe Therapeutics is the latest biotech to prepare a public listing, as...
Exact Imaging boosts U.S. commercial team for next-gen prostate cancer testing tech
about 10 hours ago
Exact Imaging is looking to broaden uptake of its high-resolution micro-ultrasound system...
Caris Life Sciences launches cancer blood test ‘Caris Detect’
about 11 hours ago
Caris Life Sciences has launched a new oncology blood test designed alongside...
Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab
about 11 hours ago
A month after Genentech confirmed the restructuring of its early development group...
Novartis to pay $1.1B upfront for UK biotech Myricx to expand the pharma's ADC pipeline
about 13 hours ago
Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront...
United Therapeutics pays $140M for thymic cell therapy startup
3 days ago
United Therapeutics has paid $140 million to buy Thymmune Therapeutics for preclinical...
AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC
3 days ago
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical...
Fosun pays $32M to join Lilly and Novartis in fiercely competitive psoriasis market
4 days ago
A Fosun Pharma subsidiary has paid Junshi Biosciences 215 million yuan ($32...
Roche orchestrates phase 3 KRAS lung cancer win over Amgen, BMS
4 days ago
Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers...
Insilico keeps partnership sprint apace in $600M biobucks collab with Takeda
5 days ago
Insilico Medicine has signed a deal worth up to $600 million with...
Merck halts ph. 2 Alzheimer’s trial after Neuphoria small molecule underwhelms
5 days ago
Merck & Co. has nixed the phase 2 study of a potential...
Zimmer Biomet buys non-drug pain relief system from Pacira for up to $140M
5 days ago
Pacira BioSciences offloaded its cold-therapy pain relief device to medtech orthopedics specialist...